New antiviral drugs mark a big turning point in the covid-19 pandemic

https://www.economist.com/science-and-technology/2021/11/12/new-antiviral-drugs-mark-a-big-turning-point-in-the-covid-19-pandemic

The new drugs are molnupiravir (Lagevrio), developed by Merck, a pharmaceutical company, working with Ridgeback Biotherapeutics, a biotech firm, and Paxlovid, which was developed by Pfizer.